Spire Wealth Management’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $108K | Buy |
2,218
+548
| +33% | +$26.7K | ﹤0.01% | 942 |
|
|
2025
Q1 | $56.8K | Sell |
1,670
-300
| -15% | -$10.2K | ﹤0.01% | 1233 |
|
|
2024
Q4 | $77.5K | Buy |
1,970
+1,482
| +304% | +$58.3K | ﹤0.01% | 1132 |
|
|
2024
Q3 | $22.9K | Sell |
488
-15
| -3% | -$705 | ﹤0.01% | 1402 |
|
|
2024
Q2 | $27.2K | Sell |
503
-2,664
| -84% | -$144K | ﹤0.01% | 1327 |
|
|
2024
Q1 | $216K | Buy |
3,167
+2,713
| +598% | +$185K | ﹤0.01% | 749 |
|
|
2023
Q4 | $28.1K | Sell |
454
-598
| -57% | -$37.1K | ﹤0.01% | 1411 |
|
|
2023
Q3 | $47.8K | Buy |
1,052
+259
| +33% | +$11.8K | ﹤0.01% | 1188 |
|
|
2023
Q2 | $44.5K | Buy |
793
+400
| +102% | +$22.5K | ﹤0.01% | 1244 |
|
|
2023
Q1 | $17.8K | Buy |
393
+20
| +5% | +$905 | ﹤0.01% | 1670 |
|
|
2022
Q4 | $15K | Hold |
373
| – | – | ﹤0.01% | 1474 |
|
|
2022
Q3 | $24K | Hold |
373
| – | – | ﹤0.01% | 1246 |
|
|
2022
Q2 | $23K | Buy |
+373
| New | +$23K | ﹤0.01% | 1604 |
|
|
2022
Q1 | – | Sell |
-1,090
| Closed | -$83K | – | 2585 |
|
|
2021
Q4 | $83K | Buy |
1,090
+990
| +990% | +$75.4K | ﹤0.01% | 1488 |
|
|
2021
Q3 | $11K | Hold |
100
| – | – | ﹤0.01% | 2060 |
|
|
2021
Q2 | $16K | Sell |
100
-288
| -74% | -$46.1K | ﹤0.01% | 1961 |
|
|
2021
Q1 | $44K | Buy |
+388
| New | +$44K | ﹤0.01% | 1786 |
|